These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31266795)

  • 1. Federal advisory council backs universal, single-payer, public pharmacare.
    Vogel L
    CMAJ; 2019 Jul; 191(26):E747-E748. PubMed ID: 31266795
    [No Abstract]   [Full Text] [Related]  

  • 2. The 2018 decision to establish an Advisory Council on adding pharmaceuticals to universal health coverage in Canada.
    Grignon M; Longo CJ; Marchildon GP; Officer S
    Health Policy; 2020 Jan; 124(1):7-11. PubMed ID: 31761273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal prescription drug coverage in Canada: Long-promised yet undelivered.
    Morgan SG; Boothe K
    Healthc Manage Forum; 2016 Nov; 29(6):247-254. PubMed ID: 27744279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Federal budget disappoints on universal pharmacare.
    Vogel L
    CMAJ; 2019 Apr; 191(14):E406-E407. PubMed ID: 30962204
    [No Abstract]   [Full Text] [Related]  

  • 5. It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.
    Lewis S
    Int J Health Policy Manag; 2020 Jan; 9(1):1-5. PubMed ID: 31902189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.
    Brandt J; Shearer B; Morgan SG
    J Pharm Policy Pract; 2018; 11():28. PubMed ID: 30443371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separated at Birth: The Politics of Pharmacare for All in Canada and Medicare for All in the United States Comment on "Universal Pharmacare in Canada".
    Tuohy CH
    Int J Health Policy Manag; 2021 Mar; 10(3):162-164. PubMed ID: 32610786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canada can afford universal pharmacare – no more excuses.
    Stanbrook MB
    CMAJ; 2015 Apr; 187(7):475. PubMed ID: 25802314
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada".
    Gagnon MA
    Int J Health Policy Manag; 2021 Mar; 10(3):168-171. PubMed ID: 32610789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare".
    Rawson NSB
    Int J Health Policy Manag; 2020 Dec; 9(12):524-527. PubMed ID: 32610769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada.
    Lexchin J
    Int J Health Serv; 2022 Jul; 52(3):341-346. PubMed ID: 35535406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canada needs universal pharmacare.
    The Lancet
    Lancet; 2019 Oct; 394(10207):1388. PubMed ID: 31631840
    [No Abstract]   [Full Text] [Related]  

  • 14. Election 2019: unprecedented hope for universal pharmacare.
    Stanbrook MB
    CMAJ; 2019 Oct; 191(41):E1116-E1117. PubMed ID: 31615817
    [No Abstract]   [Full Text] [Related]  

  • 15. How to pay for national pharmacare.
    Wolfson MC; Morgan SG
    CMAJ; 2018 Nov; 190(47):E1384-E1388. PubMed ID: 30478216
    [No Abstract]   [Full Text] [Related]  

  • 16. Six Myths About Pharmacare.
    Lexchin J
    Health Law Can; 2017 Feb; 37(2-3):44-51. PubMed ID: 30005520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Pharmacare - Redressing Social Inequities in the Canadian Health System: A Response to Recent Commentaries.
    Hajizadeh M; Edmonds S
    Int J Health Policy Manag; 2021 Jun; 10(6):356-357. PubMed ID: 32702799
    [No Abstract]   [Full Text] [Related]  

  • 18. Single payers, multiple systems: the scope and limits of subnational variation under a Federal health policy framework.
    Tuohy CH
    J Health Polit Policy Law; 2009 Aug; 34(4):453-96. PubMed ID: 19633218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada.
    Contoyannis P; Hurley J; Grootendorst P; Jeon SH; Tamblyn R
    Health Econ; 2005 Sep; 14(9):909-23. PubMed ID: 16127675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care reform: lessons from Canada.
    Deber RB
    Am J Public Health; 2003 Jan; 93(1):20-4. PubMed ID: 12511378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.